Effectiveness and Safety of Rivaroxaban Versus Warfarin among Nonvalvular Atrial Fibrillation Patients with Concomitant Obstructive Sleep Apnea

Background  Obstructive sleep apnea (OSA) is associated with an increased incidence of atrial fibrillation (AF), hypertension, diabetes, heart failure, coronary heart disease, stroke, and death. We sought to evaluate the effectiveness and safety of rivaroxaban versus warfarin in nonvalvular AF (NVAF...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Nitesh, Ashton, Veronica, Bessada, Youssef, Galli, Katelyn, Bookhart, Brahim K., Coleman, Craig I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060096/
https://www.ncbi.nlm.nih.gov/pubmed/37009629
http://dx.doi.org/10.1055/a-2013-3346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10060096/
https://www.ncbi.nlm.nih.gov/pubmed/37009629
http://dx.doi.org/10.1055/a-2013-3346

Ejemplares similares